Combining radiofrequency ablation with cervical plexus block for neck pain relief
Comparative Study Between Cervical Medial Branch Radiofrequency Ablation Versus Radiofrequency Plus Superficial Cervical Plexus Block in Treatment of the Cervical Facet and Cervical Spondylosis Pain
This study is testing if combining a specific pain relief procedure with a nerve block can help adults with neck pain from cervical spondylosis feel better compared to just the pain relief procedure alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 53 (estimated) |
| Ages | 30 Years to 70 Years |
| Sex | All |
| Sponsor | Ain Shams University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06480175 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of combining radiofrequency ablation with a superficial cervical plexus block in providing pain relief for adults suffering from cervical spondylosis. Participants will undergo a procedure where radiofrequency ablation is performed on the medial branches of the cervical facet nerves, followed by a cervical plexus block using lidocaine and triamcinolone. The study will compare pain relief outcomes between those receiving the combined treatment and those receiving radiofrequency ablation alone. Patients will be monitored throughout the procedure to ensure safety and efficacy.
Who should consider this trial
Good fit: Ideal candidates are adults aged 30-70 with cervical spondylosis pain who have not responded to conservative treatments.
Not a fit: Patients with neurological disorders, coagulopathy, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide enhanced pain relief for patients suffering from chronic neck pain due to cervical spondylosis.
How similar studies have performed: Previous studies have shown promising results with similar pain management techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Both genders. * Age between 30-70 years. * American society of anesthesiologist ASA 1,2 \& 3 physical status. * MRI cervical spine diagnosing cervical facet arthropathy originating pain . * Failed full dose medical treatment and life style modification and physiotherapy for 3 months prior to intervention. Exclusion Criteria: * Neurological disorders.(previous central and peripheral CNS affection ). * coagulopathy INR \> 1.8 or platelets \< 50,000. * Infection at or near the injection site. * Presence of pacemaker or defibrillator. * known allergy to used medications. * age \>70 or \<30 years. * patients with previous history of Radiotherapy , chemotherapy or metastasis * pregnant patients. * patients with rheumatological disorders ( rheumatoid arthritis, diffuse idiopathic skeletal hyerostosis, psoriatic arthritis, spondyloarthritis) * patients with antiphospholipid syndtrome.
Where this trial is running
Cairo
- Ain Shams University Hospital — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: lydia zakhary, MD — Ain Shams University
- Study coordinator: lydia zakhary
- Email: lydia_zakhary@med.asu.edu.eg
- Phone: 01222555128
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.